AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
VolitionRx Secures $2.4 Million Through Convertible Note Issuance
VolitionRx Limited announced the issuance of a senior secured convertible promissory note worth $2.4 million. This funding will support the company's ongoing development of blood-based cancer diagnostics. The company also satisfied conversion obligations via the issuance of shares of common stock. This capital infusion will aid in advancing technology and operational growth.
Company Information
Company
VolitionRx
Location
Henderson, Nevada, United States
About
VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis.
Fundz sees it the moment VolitionRx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
HendersonBiotechnologyHealth CareGeneticsTherapeutics